AllPennyStocks.com Adobe Systems (ADBE) Outpaces Stock Market Gains: What You Should Know
This section contains press releases and other materials from third parties (including paid content). AllPennyStocks.com has not reviewed this content. Please see our disclaimer.

Adobe Systems (ADBE) Outpaces Stock Market Gains: What You Should Know

Adobe Systems (ADBE) closed the most recent trading day at $275.30, moving +1.13% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.44%. Elsewhere, the Dow gained 0.98%, while the tech-heavy Nasdaq added 0.44%.

Prior to today's trading, shares of the software maker had gained 28.3% outpaced the Computer and Technology sector's gain of 2.49% and the S&P 500's gain of 2.81%.

Investors will be eagerly watching for the performance of Adobe Systems in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on September 10, 2026. The company's earnings per share (EPS) are projected to be $6.08, reflecting a 14.5% increase from the same quarter last year. Simultaneously, our latest consensus estimate expects the revenue to be $6.69 billion, showing a 11.75% escalation compared to the year-ago quarter.

For the annual period, the Zacks Consensus Estimates anticipate earnings of $24.31 per share and a revenue of $26.56 billion, signifying shifts of +16.09% and +11.74%, respectively, from the last year.

It is also important to note the recent changes to analyst estimates for Adobe Systems. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.

Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.

The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. At present, Adobe Systems boasts a Zacks Rank of #2 (Buy).

Valuation is also important, so investors should note that Adobe Systems has a Forward P/E ratio of 11.2 right now. This denotes a discount relative to the industry average Forward P/E of 17.38.

Also, we should mention that ADBE has a PEG ratio of 0.75. Comparable to the widely accepted P/E ratio, the PEG ratio also accounts for the company's projected earnings growth. Computer - Software stocks are, on average, holding a PEG ratio of 1.55 based on yesterday's closing prices.

The Computer - Software industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 63, putting it in the top 26% of all 250+ industries.

The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

To follow ADBE in the coming trading sessions, be sure to utilize Zacks.com.

Beyond Nvidia: AI's Second Wave Is Here

The AI revolution has already minted millionaires. But the stocks everyone knows about aren't likely to keep delivering the biggest profits. AI’s second wave is moving from infrastructure to implementation and these companies are at the forefront of this transition, positioned to become what Amazon and Google were to the internet era.

See Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Adobe Inc. (ADBE): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Other Penny Stock Movers

65,000 Patients a Year, Zero Approved Drugs, One Phase 3 Trial
$4.5 Million Could Unlock a Major Cannabis Market
Chilean Gold Developer Gains 15% on Final Permit Clearance


Back to Top